[1] Lan H, Lu H, Wang X, et al. MicroRNAs as potential biomarkers in cancer: opportunities and challenges[J]. Biomed Res Int, 2015, 2015:125094.
[2] Price C, Chen J. MicroRNAs in cancer biology and therapy: current status and perspectives[J]. Genes Dis, 2014, 1(1):5363.
[3] Frank B, Maximilian FR. MicroRNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?[J]. Theranostics, 2013, 3(12):943952.
[4] Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communications in cardiovascular disease[J]. Circ Res, 2012, 110(3):483495.
[5] Haque R, Hur EH, Farrell AN, et al. MicroRNA152 represses VEGF and TGFβ1 expressions through posttranscriptional inhibition of prorenin receptor in human retinal endothelial cells[J]. Mol Vis, 2015, 21:224235.
[6] Taft RJ, Pang KC, Mercer TR, et al. Noncoding RNAs: regulators of disease[J]. J Pathol, 2010, 220(2):126139.
[7] Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large Bcell lymphoma[J]. Br J Haematol, 2008, 141(5):672675.
[8] Chen X, Ba Y, Ma L, et al. Criculation of micorRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10):9971006.
[9] Brase JC, Wutting D, Kuner R, et al. Serum microRNAs as noninvasive biomarkers for cancer [J]. Mol Cancer, 2010,9:306314.
[10] Kroh EM, Parkin PK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcriptionPCR(qRTPCR)[J]. Methods, 2010,50(4): 298301.
[11] McDonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges[J]. Clin Chem, 2011,57(6):833840.
[12] Camarillo C, Swerdel M, Hart RP. Comparison of microarray and quantitative realtime PCR methods for measuring microRNA levels in MSC cultures[J]. Methods Mol Biol, 2011,698:419429.
[13] Bianchi F, Nicassio F, Verones G, et al. Circulating microRNAs: next generation biomarkers for early lung cancer detection[J]. Ecancermedicalscience, 2012, 6:246.
[14] Aushev VA, Zborovshaya IB, Laktionov K, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma[J]. PLoS One, 2013, 8(10):e78649.
[15] Kaduthanam S, Gade S, Meister M, et al. Serum miR1423p is associated with early relapse in operable lung adenocarcinoma patients[J]. Lung Cancer, 2013, 80(2):223227.
[16] Franchina T, Amodeo V, Bronte G, et al. Circulating miR22, miR24 and miR34a as novel predictive biomarkers to pemetrexedbased chemotherapy in advanced nonsmall cell lung cancer[J]. J Cell Physiol, 2014, 229(1):9799.
[17] Zhang H, Su Y, Xu F, et al. Circulating microRNAs in relation to EGFR status and survival fo lung adenocarcinoma in female nonsmokers[J]. PLoS One, 2013, 8(11):e81408.
[18] Markou A, Sourvinou I, Vorkas PA, et al. Clinical evaluation of microRNA expression profiling in non small cell lung cancer[J]. Lung Cancer, 2013, 81(3):388396. |